BARBA, Thomas et al. Efficacy and safety of infliximab therapy in refractory upper respiratory tract sarcoidosis: experience from the STAT registry. Sarcoidosis, Vasculitis and Diffuse Lung Diseases, Fidenza, Italy, v. 34, n. 4, p. 343–351, 2018. DOI: 10.36141/svdld.v34i4.5817. Disponível em: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/5817.. Acesso em: 18 jul. 2024.